Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
CIN Special Report: Part I, Can a Dangerous Pre-Cancer Threat Be Tamed?
In response to some recent successes by several companies operating in the cervical cancer space, we are issuing a two-part special report exploring pre-cervical cancer and CIN.
OneMedRadio Discusses Gene Therapy and Diagnostics with Dr. Andrew Senyei
OneMedRadio interviewed, Andrew Senyei, an MD with an interest in individualized DNA sequencing and gene therapy for heart disease.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Complete Genomics Well Positioned to Move from Research to Clinical in Genome Sequencing
OneMedRadio recently conducted an interview with Dr. Clifford A. Reid, the company’s President and Chief Executive Officer.
Advaxis Receives Best Therapeutic Vaccine Award
The 5th Annual Vaccine Industry Excellence Awards has named Advaxis as the Best Therapeutic Vaccine for the company’s ADVX-HPV construct.
Dr. Cynthia Haines, Health Information Guru: How Patients Can Combat a Broken Healthcare System
In this unprecedented age of technology and communication, many wonder why the healthcare industry has traditionally not been on the cutting edge.
Patent Infringement Special Report: Part II, History and Precedent
Part two of our Special Report highlight an important case that may significantly affect the patent infringement landscape. Shares of Myriad Genetics fell 10 percent in the wake of the Mayo ruling.
